Author Archives for Thomas.hauschildt1

Join us for an exciting community event that opens the door to the world of life sciences

October 30, 2025 1:29 pm Published by Comments Off on Join us for an exciting community event that opens the door to the world of life sciences

Aimed at college students (16+) and adults in the early stages of their Life Sciences career journeys, this event is your chance to explore career opportunities, meet industry experts, and take part in hands-on activities that bring science to life. If you are an employer, we invite you to showcase your achievements and engage with future talent. Why Attend as...


Advancing Global Cancer Research at the Barts Cancer Institute: Driving innovation from lab to clinic in North East London

October 1, 2025 1:02 pm Published by Comments Off on Advancing Global Cancer Research at the Barts Cancer Institute: Driving innovation from lab to clinic in North East London

Cancer remains one of the world’s most complex health challenges, but in East London, collaboration is accelerating progress. The Barts Cancer Institute, based at Queen Mary University of London, is home to world-leading research in cancer biology and treatment. Within it, the Centre for Experimental Cancer Medicine – jointly embedded in Queen Mary and Barts Health NHS Trust – is...


Barts Health and ABHI Partner to Accelerate HealthTech Innovation – A Boost for Barts Life Sciences

September 25, 2025 8:05 am Published by Comments Off on Barts Health and ABHI Partner to Accelerate HealthTech Innovation – A Boost for Barts Life Sciences

Barts Health NHS Trust has signed a new Memorandum of Understanding (MoU) with the Association of British HealthTech Industries (ABHI) to drive the adoption of cutting-edge health technologies that improve care, reduce health inequalities, and empower clinical teams. This collaboration aims to build a stronger health innovation cluster by bringing industry, academia, and frontline clinicians together to co-develop and scale...


Leveraging technology to diversify clinical trial participation 

August 13, 2025 1:38 pm Published by Comments Off on Leveraging technology to diversify clinical trial participation 

Clinical trials often lack diversity with ethnic minorities being underrepresented. This imbalance can lead to treatments that are less effective for certain populations, reinforcing existing health inequalities. Caring for a population of around 2.5 million people representing 97 nations, Barts Health NHS Trust is well positioned to change this.  Barts Health is already routinely capturing the diversity of research participants...


One in 17 of us will develop a rare disease. Would you want to know if you’re one of them?

May 27, 2025 2:56 pm Published by Comments Off on One in 17 of us will develop a rare disease. Would you want to know if you’re one of them?

Hiba Junaid, Data Scientist at Barts Life Sciences and Suthesh Sivapalaratnam, Consultant Haematologist at Barts Health, spoke at the Barts Health flagship event celebrating International Clinical Trials Day and its contribution to detecting rare diseases through the use of AI.  Rare diseases affect over 3.5 million people in the UK alone, yet it can take nearly 5 years on average...


How the NHS and academia collaborate to speed up diagnosis for blood disorders  

May 27, 2025 12:11 pm Published by Comments Off on How the NHS and academia collaborate to speed up diagnosis for blood disorders  

In the UK, millions of people are affected by blood disorders. These range from common conditions like anaemia to life-threatening diseases such as leukaemia and lymphoma, with over 41,000 people diagnosed with blood cancer each year.1  Providing a fast and accurate diagnosis for these disorders is essential to ensure timely treatment and improve patient outcomes. However, the diagnosis is a...


The UK’s clinical research landscape: Can we keep our competitive edge in the life sciences? 

May 20, 2025 9:45 am Published by Comments Off on The UK’s clinical research landscape: Can we keep our competitive edge in the life sciences? 

We are celebrating International Clinical Trials Day to highlight the groundbreaking work being done across Barts Health and Queen Mary University of London. The clinical research landscape in the UK brims with opportunity and innovation, and offers significant return on investment. We spoke with Jenny Rivers, Director of Research & Development at Barts Health NHS Trust and Academy of Medical Sciences...


Supporting SMEs to get NHS-ready

May 14, 2025 12:56 pm Published by Comments Off on Supporting SMEs to get NHS-ready

Small and medium-sized enterprises (SMEs) play a key role in driving forward innovation in the NHS. At Barts Life Sciences, we support SMEs and NHS teams to learn from each other and create a better understanding of barriers and opportunities. As a result, we improve outcomes for patients, save money for the NHS, and support SMEs to grow.  Over the...


From research to real-world impact: The launch of the Academic Centre for Healthy Ageing

May 2, 2025 1:06 pm Published by Comments Off on From research to real-world impact: The launch of the Academic Centre for Healthy Ageing

We are delighted to celebrate the official launch of the Academic Centre for Healthy Ageing (ACHA) – a new joint initiative between Barts Health NHS Trust and Queen Mary University of London, supported by Barts Charity.   Based at Whipps Cross Hospital, ACHA will act as a hub for interdisciplinary research, community engagement, and clinical excellence focused on ageing well.   It...


Launching the Barts Health Data Platform

April 25, 2025 2:26 pm Published by Comments Off on Launching the Barts Health Data Platform

The healthcare landscape is undergoing a profound transformation with the integration of advanced data science and AI technologies. Leading this change is Barts Health NHS Trust, one of the largest in the UK, which has launched the Barts Health Data Platform (BHDP) in April 2025. This innovative Secure Data Environment (SDE) service provides access to over 2.5 million identified, pseudoanonymised...